CD antigens 2002.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Biomedical subjects
Derek Hart
Publications and source records attributed to Derek Hart.
Reference: CD Antigens 2002.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Technology evaluation: APC-80200, Dendreon.
APC-80200 (Mylovenge) has been developed for the treatment of B-cell malignancies and is currently in phase II clinical trials as a therapeutic vaccine for patients with advanced multiple myeloma. This vaccine candidate appears to be of particular benefit in patients who have received high-dose chemotherapy to reduce tumor load following stem cell rescue. APC-80200 is also being tested in patients with amyloidosis.
Cancer Vaccines↗